Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1988-10-14
1990-05-01
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
536 27, 435320, 4352523, 435 6951, 530351, A61K 4502, C12N 1500, C07H 2104
Patent
active
049216996
ABSTRACT:
A polypeptide having interferon activity which has an amino acid sequence corresponding to an amino acid sequence of an interferon selected from rIFN-.alpha., hybrid rIFN-.alpha., rIFN-.beta. and rIFN-.gamma. interferons in which at least one cysteine residue in the amino acid sequence has been replaced by an amino acid residue which is incapable of forming intermolecular disulfide bonds is provided. There are also provided a dsDNA sequence encoding the novel polypeptide; a replicable plasmidic expression vehicle containing the dsDNA encoding the novel polypeptides of the invention; a microorganism which has been transformed with the replicable plasmidic expression vehicle; and a method of preparing the dsDNA which encodes the novel polypeptides of the invention.
REFERENCES:
patent: 4457867 (1984-07-01), Ishida
patent: 4518584 (1985-05-01), Mark et al.
patent: 4737462 (1988-04-01), Mark et al.
Arnheifer et al., Nature, 294: 278 (1981).
Shepard et al., Nature, 294: 563 (1981).
DeChiara Thomas M.
Tarnowski, Jr. Stanley J.
Epstein William H.
Gould George M.
Hazel Blondel
Hoffman-La Roche Inc.
LandOfFree
Polypeptides having interferon activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptides having interferon activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides having interferon activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-828538